Oncology Institute (TOI) Debt to Equity (2020 - 2025)
Oncology Institute's Debt to Equity history spans 6 years, with the latest figure at -$4.92 for Q4 2025.
- For Q4 2025, Debt to Equity fell 118.97% year-over-year to -$4.92; the TTM value through Dec 2025 reached -$4.92, down 118.97%, while the annual FY2025 figure was -$4.92, 118.97% down from the prior year.
- Debt to Equity reached -$4.92 in Q4 2025 per TOI's latest filing, up from -$6.21 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $25.95 in Q4 2024 to a low of -$8.35 in Q2 2025.
- Average Debt to Equity over 5 years is $2.53, with a median of $0.99 recorded in 2023.
- Peak YoY movement for Debt to Equity: surged 37153.86% in 2022, then crashed 371.11% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.0 in 2021, then soared by 37153.86% to $0.65 in 2022, then skyrocketed by 132.63% to $1.52 in 2023, then surged by 1604.26% to $25.95 in 2024, then crashed by 118.97% to -$4.92 in 2025.
- Per Business Quant, the three most recent readings for TOI's Debt to Equity are -$4.92 (Q4 2025), -$6.21 (Q3 2025), and -$8.35 (Q2 2025).